New transplant matching method could predict organ failure

NCT ID NCT07269275

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at over 5,500 kidney transplant patients to see if a more detailed way of matching donors and recipients—called HLA eplet mismatches—can better predict long-term transplant failure than standard methods. The goal is to improve how doctors assess risk and manage patients after a kidney transplant. No new treatment was tested; instead, researchers analyzed existing data to see if this refined matching approach adds value.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could lead to a more accurate way to predict kidney transplant failure, helping doctors personalize care and improve transplant longevity.

What could go wrong

This is an observational study, not a treatment trial. It may not prove that eplet mismatches are better than current methods, and results may not change clinical practice.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for KIDNEY TRANSPLANT FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Paris Translational Research Center for Organ Transplantation

    Paris, France